We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AIG:NYSEAmerican International Group, Inc. New Analysis

Data as of 2026-03-10 - not real-time

$77.62

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

American International Group (AIG) is trading at $77.62, just above its 20‑day SMA of 79.01 and comfortably above the 50‑day SMA of 77.83, while the 200‑day SMA sits near 79.90, indicating a neutral price stance. The 14‑day RSI of 46.3 suggests the stock is neither overbought nor oversold, and the MACD histogram is negative with a bearish signal, pointing to short‑term downside pressure. AIG holds strong support at $74.56 and faces resistance near $81.62, with a 30‑day volatility of 23.9% and a low beta of 0.55, implying modest market sensitivity.
Fundamentally, the company posted a 51% YoY jump in Q4 adjusted EPS to $1.96, beating estimates, and generated $11.26 B of free cash flow, supporting its 2.32% dividend yield and a modest 32% payout ratio. Despite a 7.2% revenue decline, margins remain healthy (gross 34.1%, operating 13.8%) and the forward PE of 8.76 is well below the industry average of 17.38, signaling relative undervaluation. The DCF‑derived fair value of $292.7 suggests a potential upside of roughly 12.7% from current levels, and the “Extreme Greed” sentiment in the fear‑greed index adds momentum to the bullish case.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near short‑term support levels
  • Bearish MACD signal
  • Neutral RSI and stable volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong EPS beat and free cash flow generation
  • Undervalued valuation multiples versus peers
  • Attractive dividend yield with sustainable payout

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • DCF fair‑value indicating significant upside
  • Strategic acquisitions expanding growth platform
  • Resilient business model across diversified insurance segments

Key Metrics & Analysis

Financial Health

Revenue Growth-7.20%
Profit Margin11.63%
P/E Ratio14.3
ROE7.40%
ROA1.73%
Debt/Equity24.41
P/B Ratio1.0
Op. Cash Flow$3.3B
Free Cash Flow$11.3B
Industry P/E17.4

Technical Analysis

TrendNeutral
RSI46.3
Support$74.56
Resistance$81.62
MA 20$79.01
MA 50$77.83
MA 200$79.90
MACDBearish
VolumeStable
Fear & Greed Index80.45

Valuation

Fair Value$292.71
Target Price$87.45
Upside/Downside12.66%
GradeUndervalued
TypeValue
Dividend Yield2.32%

Risk Assessment

Beta0.56
Volatility23.91%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.